Coronary artery disease (CAD) is a leading cause of morbidity and mortality in women and non-invasive testing for CAD in women can be more challenging than in men. This study compared the diagnostic performance of whole-heart dynamic 3D cardiovascular magnetic resonance (CMR) stress perfusion imaging in female and male patients with quantitative coronary angiography (QCA) and fractional flow reserve (FFR) as reference tests. 
Introduction
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide and contributes to a larger relative and absolute amount of deaths in women compared with men 1 with coronary artery disease (CAD) being responsible for the majority of deaths not only in Europe, but also in the USA. 2 Although female patients have been underrepresented in clinical trials, 3 assumptions on the performance of diagnostic tests and treatment of CAD have been transferred from predominantly middleaged male study populations to females, hereby disregarding differences in prevalence, symptoms and pathophysiology of myocardial ischaemia between the genders. 4 Non-invasive testing of myocardial ischaemia is a central diagnostic tool in the assessment of CAD but diagnostic modalities show different performances in women and men. The Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) study found a higher diagnostic sensitivity, negative predictive value and positive predictive value of vasodilator perfusion stress cardiovascular magnetic resonance (CMR) imaging compared with vasodilator perfusion stress single photon emission computed tomography (SPECT). 5 These findings were pronounced in the female subgroup. 6 Not only functional noninvasive test results differ with respect to gender but also anatomical tests like computed tomography angiography (CTA). The Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial showed that men are more likely to have a positive CTA test result than a positive functional test result. Whereas women are more likely to have a positive functional, than a positive CTA test result. 7 These differences in non-invasive testing point to the need for a gender specific approach for the assessment of CAD.
A recent multi-centre study demonstrated that whole-heart dynamic 3D CMR stress perfusion imaging has high diagnostic accuracy Figure 1 Example of whole-heart 3D CMR perfusion images during adenosine stress (panel A), rest (B) and late gadolinium enhancement images (LGE) (C) of a female patient without significant myocardial hypoperfusion or myocardial scar. Panel D shows the corresponding coronary angiography without relevant stenosis of LAD and RCX; Fractional flow reserve (FFR) performed for the stenosis of the descending RCA was not haemodynamically significant (FFR = 0.91, panel E
for the assessment of CAD. 8, 9 The aim of the present study was to determine the relative performance of whole-heart dynamic 3D CMR stress perfusion imaging as a non-invasive test for the detection of CAD in female and male patients.
Methods

Study population
Patients from five European centres (University Hospital Zurich, Switzerland; University Hospital RWTH Aachen, Germany; German Heart Institute Berlin, Germany; King's College London, United Kingdom; University of Leeds, UK) referred for coronary angiography between 2009 and 2013 with known or suspected CAD (previous myocardial infarction >3 months) were included and underwent whole-heart dynamic 3D stress perfusion imaging prior to coronary angiography. Participant data has been published earlier. [8] [9] [10] Patients were instructed to refrain from caffeine-containing substances 24 h before CMR. Exclusion criteria were the known contraindications for CMR. This study complies with the declaration of Helsinki, was approved by the local ethics committees in each contributing centre and all patients provided written informed consent. The analysis focused on diagnostic accuracy of whole-heart dynamic 3D stress perfusion CMR with respect to gender.
Cardiovascular magnetic resonance
CMR was, depending on the centres' facilities, conducted on 3.0 or 1.5 T MR systems (Philips Healthcare, Best, The Netherlands). A vector ECG was used for cardiac synchronization and either 5-, 6-, 28-or 32-channel torso coil arrays were used for signal reception. As provided by the study protocol standard cine scans followed by dynamic whole-heart 3D perfusion imaging at stress/rest and late gadolinium enhancement (LGE) images (Figures 1 and 2) were performed as previously described. [8] [9] [10] Standard dosing of adenosine (140 lg/kg/min) was not modified. 
Quantification of myocardial ischaemia
Visual analysis of CMR images took place in a central data analysis laboratory (University Heart Center Zurich) by reviewers blinded to clinical and angiographic data using a dedicated workstation (ExtendedWorkSpace, Philips Healthcare, Best, The Netherlands). The number of acquired slices was adapted to the heart size and ranged from 9 to 16. The subset of short axis slices showing more than 75% circumferential left ventricular myocardium and clearly identifiable left ventricular cavity during contrast agent passage was determined. Myocardial ischaemia was estimated by quantification of hypoenhanced myocardium in the dynamic stress perfusion scan. The examination was rated positive for myocardial ischaemia, if a perfusion defect (transmurality > _25%) in any segment was identified that persisted for more than three dynamics, was not visible at rest and showed no myocardial scar defined as positive LGE. After selecting the dynamic frame showing the maximum extent of myocardial hypo-enhancement during peak signal enhancement of remote myocardium, delineation of endocardial and epicardial borders was performed manually. Hypoenhanced myocardium was quantified automatically based on a signal intensity threshold >2Â standard deviation (SD) below the signal of remote myocardium. Total myocardial volume and hypoenhanced myocardial volumes were calculated by the disk summation method. In case of myocardial scarring as defined by LGE images, quantification of scar volume was performed accordingly and was subtracted from the volume of myocardial hypo-enhancement and normalized to total left ventricular volume. The myocardial ischaemic burden (MIB) was calculated as the hypoenhanced myocardial volume relative to the total myocardial volume expressed in per cent. Quantification of tissue volumes was performed using dedicated software (GTVolume, GyroTools LLC, Zurich, Switzerland). Moreover transmurality of each myocardial segment showing a perfusion deficit was graded from 0 (no perfusion deficit), 1 (25% transmurality), 2 (26-50% transmurality), 3 (51-75% transmurality) to 4 (>75% transmurality) and summed to a perfusion score, which was used as primary measure of myocardial ischaemia. To correct for different heart sizes perfusion scores were normalized to an average number of 12 myocardial slices. Allocation of a perfusion defect was based on the 17-segment AHA model.
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Coronary angiography
Coronary angiography was conducted according to a standardized, routine protocol. Every major coronary vessel and its side branches were depicted in at least two orthogonal views. Angiograms were analysed off-line and quantitative coronary angiography (QCA) was processed by an independent core laboratory (German Heart Institute Berlin) being blinded to the CMR results. QCA was performed in all patients and FFR in 357 of 416 patients. Significant coronary stenosis was defined by > _50% of coronary artery diameter stenosis. FFR was performed as described before 12 when vessel diameter was visually categorized as having > _50 and < _80% diameter stenosis in two orthogonal views with > _2 mm luminal diameter. A controlled pull-back procedure was not routinely performed. Coronary stenosis >80%, total or subtotal occlusion or an FFR value <0.8 was classified as haemodynamically relevant. 13 Vessels with less than 2 mm luminal diameter were considered non-significant.
Statistical analysis
Data analysis was performed using MedCalc (MedCalc Software, Ostend, Belgium). Data were evaluated on a patient basis. Using summed perfusion score as primary measure for myocardial ischaemia, sensitivity, specificity, positive, and negative predictive values with corresponding 95% confidence intervals (95% CI) were calculated (diagnostic criterion cutoff >0 
Results
Patient characteristics
Patient characteristics are listed in Table 1 . The study-population consisted in total of n = 416, including n = 119 women (65 ± 11 years) and n = 297 men (63 ± 11 years). Table 2 shows the haemodynamic parameters during the CMR examination.
Diagnostic performance
The prevalence of CAD defined by QCA > _ 50% related to the entire study population was 56% (234 of 416 patients). Prevalence in the female group was 45% (53 of 119) and 61% (181 of 297) in the male group. When using FFR (<0.8) as the reference, the prevalence of haemodynamically relevant CAD in the entire group was 48% (171 of 357). The prevalence of FFR-defined haemodynamically significant CAD in females was lower with 36% (38 of 106) compared with 53% (133 of 251) in the male group. When analysed per patient, sensitivity and specificity of wholeheart dynamic 3D CMR stress perfusion imaging were 89% (95% CI: 77-96) and 82% (95% CI: 70-90) in the female study population and 83% (95% CI: 77-89) and 79% (95% CI: 71-86) in the male study population, relative to the QCA reference ( Table 3) . Except for negative predictive value (NPV) (P < 0.05) there were no significant differences between female and male.
When using FFR as the reference, sensitivity and specificity were 95% (95% CI: 82-99) and 84% (95% CI: 73-92) in the female and 83% (95% CI: 78-89) and 82% (95% CI: 74-89) in the male study population. Diagnostic accuracy in the female group was 92% (95% CI: 85-96) and 86% (95% CI: 81-90) in the male group ( Figure 3, Table 3 ). Except for negative predictive value (NPV) (P < 0.05) there were no significant differences between female and male. Results for the detection of single-and multi-vessel disease in female and male, when using FFR as the reference, are shown in Table 4 . Results per vessel territory in female and male, when using FFR as the reference are given in Table 5 . We separately analysed the data derived by 1.5 and 3.0 T for female and male as given in Supplementary data online, Tables S1-S3.
Myocardial ischaemic burden
Including all patients, the mean MIB was 9.9% ± 13.5%. There was no significant difference in MIB between women and men (9.3% ±14.0% in the female group and 10.1% ± 13.3 in the male group (P = 0.613)) ( Figure 4) .
Discussion
Whole-heart dynamic 3D CMR stress perfusion imaging is a novel tool for non-invasive testing in CAD and has proven its diagnostic robustness and its high diagnostic accuracy in several previous studies. 8, 9 As non-invasive testing for obstructive CAD in women is challenging, the present study evaluated gender based diagnostic performance of whole-heart dynamic 3D CMR perfusion imaging. The main findings of the present study are (i) diagnostic accuracy of . whole-heart dynamic 3D CMR stress perfusion imaging to detect functionally relevant CAD in females is as high as in males.
(ii) There are no significant differences regarding sensitivity, specificity and PPV between women and men. (iii) Diagnostic accuracy in detecting single-and multi-vessel disease in females is as high as in males. The prevalence of CAD as defined by FFR (48% overall, 36% female group, 53% male group) reflects an average value in an intermediate risk population referred to CMR stress perfusion imaging. The present study has included a large number of females and is the first to assess diagnostic accuracy of whole-heart dynamic 3D CMR stress perfusion imaging with FFR as reference in females.
Both functional and anatomic non-invasive testing modalities for CAD show different diagnostic performance with respect to gender. Indeed, females with suspected CAD are less likely to have a positive CTA examination than a positive functional non-invasive test, while males with suspected CAD are less likely to have a positive functional non-invasive test than a positive CTA. 7 These differences were explained by a higher prevalence of microvascular coronary dysfunction and therefore more false-positive functional non-invasive tests in females. 7 Additional reasons may be a higher incidence of single vessel disease 4 and a more frequent occurrence of intermediate-grade stenosis in female. 14 Comparing perfusion CMR with myocardial perfusion SPECT, the CE-MARC trial showed inferiority of the diagnostic performance of myocardial perfusion SPECT for detection of obstructive CAD especially in females, rather due to smaller heart size than breast attenuation. 6 ,7,15 2D three-slice perfusion CMR has proven its high sensitivity and specificity relative to the FFR reference 16 and has shown its relevance for non-invasive testing in CAD for both genders 17, 18 avoiding the use of ionizing radiation. Whole-heart dynamic 3D CMR stress perfusion imaging has as well proven its high diagnostic accuracy relative to the FFR reference, adding the opportunity to quantify MIB. 9, 10 In addition, the MIB derived from whole-heart dynamic 3D CMR stress perfusion imaging has shown to agree well with the cut-off value >10% of myocardial ischaemia recommending coronary artery revascularization when comparing to myocardial perfusion scintigraphy. 19 However, women are still undertreated as seen in Table 1 . A lower prevalence of CAD in female even in the presence of chest pain 20 and less predictive and atypical symptoms 15 might cause this undertreatment. Notably, women with CAD have more adverse outcomes compared with men. 21 Thus, accurate diagnostic assessment of CAD and optimal therapy is crucial to improve prognosis in women. Data for non-invasive CAD tests obtained specifically in symptomatic women are limited. Therefore, numerous coronary angiographies are performed showing no pathological findings, leading to avoidable interventional risks, radiation exposure and preventable expenses. 16 To overcome the challenges caused by lower pretest probability and different disease pathophysiology in female, it is recommended to apply non-invasive diagnostic tests providing high sensitivity and 22 The present study showed high sensitivity and even a higher NPV in female for whole-heart dynamic 3D CMR stress perfusion imaging compared with male and therefore might be especially suitable as non-invasive testing tool in females. Given the favourable signal to noise ratio for 3.0 T field strength and subsequently the assumable more accurate performance of the 3.0 T subgroup, analysis was performed separately for 3.0 and 1.5 T but showed no significant difference between female and male; except for NPV indicating an advantage for 3.0 T field strength in female when analysed on a perpatient level. Analysis on a per-territory level showed some significant differences in favour for 1.5 T. Taking into account the low PPV values on a territory-level, evaluation of a known coronary artery stenosis might be limited due to technical limitations regarding spatial resolution and image quality. Furthermore myocardial segments are assigned to coronary arteries following the 17-AHA model disregarding individual variations causing lower sensitivity on a per-territory level. 23, 24 Nevertheless, the NPV regarding the territory level analysis is excellent and allows reliable exclusion of CAD avoiding further unnecessary diagnostic or interventional approaches. Quantification of myocardial perfusion might add interesting additional information 25 but was not possible from the acquired data in the present study. Further studies should implement this analysis to establish thresholds for cardiovascular risk stratification and outcome prediction in female patients.
Study limitations
Recruitment of patients was conducted from patients already scheduled for coronary angiography, reflecting current referral by external physicians. FFR was performed in vessels showing luminal stenosis of 50-80% only, without performing a controlled pull-back procedure. Absolute Quantification of myocardial perfusion was not possible from the acquired data. MIB was provided as percentage ischaemic myocardium, reflecting a relative myocardial perfusion distribution at one particular time point in first-pass perfusion and is therefore no measure of quantitative myocardial blood flow. Standard dosing of adenosine was not modified which might have caused an inadequate effect and underestimation of myocardial ischaemia in some individuals. Finally, the examinations were performed on 1.5 and 3.0 T.
Conclusion
The present study shows that whole-heart dynamic 3D CMR stress perfusion imaging has a high diagnostic performance for the detection of haemodynamically relevant CAD in both genders. 
